DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Lee ST, Jang JH, Suh HC. et al.
Idarubicin, cytarabine, and topotecan in patients with refractory or relapsed acute myelogenous leukemia and high-risk myelodysplastic syndrome.
Am J Hematol 2001;
68: 237-245.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.